CORVUS PHARMACEUTICALS INC's ticker is CRVS and the CUSIP is 221015100. A total of 67 filers reported holding CORVUS PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.39 and the average weighting 0.2%.
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ADAMS STREET PARTNERS LLC | 2,687,381 | $38,430,000 | 10.58% |
Novo Holdings A/S | 3,224,046 | $46,104,000 | 4.39% |
SPHERA FUNDS MANAGEMENT LTD. | 320,229 | $4,579,000 | 1.16% |
Orbimed Advisors | 5,379,349 | $76,925,000 | 0.98% |
Avoro Capital Advisors LLC | 216,619 | $3,098,000 | 0.63% |
Rock Springs Capital Management LP | 450,000 | $6,435,000 | 0.43% |
Cormorant Asset Management, LP | 198,526 | $2,839,000 | 0.38% |
EverPoint Asset Management, LLC | 417,849 | $5,975,000 | 0.11% |
ESSEX INVESTMENT MANAGEMENT CO LLC | 21,292 | $304,000 | 0.05% |
PRELUDE CAPITAL MANAGEMENT, LLC | 9,402 | $134,000 | 0.02% |